BACKGROUND: Urinary tract infections (UTI), the most common infectious complications after kidney transplantation, are associated with poor allograft survival. Identifying its predisposing factors is therefore remarkably important in order to optimize prevention strategies. MATERIAL AND METHODS: A retrospective study was performed in a cohort of patients who received kidney transplantation between June 2007 and June 2009. Factors associated with development of UTI were assessed. RESULTS: The population consisted of 301 patients, with majority receiving allograft from living donors (85%). A total of 101 patients (34%) developed at least one episode of UTI, and 25% of the episodes occurred during the first year after transplantation. Risk factors associated with increased risk of UTI were female gender, recurrent UTI prior to transplant, and presence of urological abnormalities. Trimethoprim-sulfamethoxazole (TMP-SMZ) use was associated with a lower risk of UTI, including a lower risk of recurrent UTI. CONCLUSIONS: In this cohort of predominantly living donor kidney transplant recipients, we report a high incidence of UTI, despite our practice of early ureteral and Foley catheter removal. Female gender and prior recurrent UTI or urological abnormalities were predisposing factors, while TMP-SMZ use had a protective role. These clinical relevant findings should guide clinicians in optimizing prevention strategies against UTI in kidney transplant recipients.
BACKGROUND:Urinary tract infections (UTI), the most common infectious complications after kidney transplantation, are associated with poor allograft survival. Identifying its predisposing factors is therefore remarkably important in order to optimize prevention strategies. MATERIAL AND METHODS: A retrospective study was performed in a cohort of patients who received kidney transplantation between June 2007 and June 2009. Factors associated with development of UTI were assessed. RESULTS: The population consisted of 301 patients, with majority receiving allograft from living donors (85%). A total of 101 patients (34%) developed at least one episode of UTI, and 25% of the episodes occurred during the first year after transplantation. Risk factors associated with increased risk of UTI were female gender, recurrent UTI prior to transplant, and presence of urological abnormalities. Trimethoprim-sulfamethoxazole (TMP-SMZ) use was associated with a lower risk of UTI, including a lower risk of recurrent UTI. CONCLUSIONS: In this cohort of predominantly living donor kidney transplant recipients, we report a high incidence of UTI, despite our practice of early ureteral and Foley catheter removal. Female gender and prior recurrent UTI or urological abnormalities were predisposing factors, while TMP-SMZ use had a protective role. These clinical relevant findings should guide clinicians in optimizing prevention strategies against UTI in kidney transplant recipients.
Authors: Friederike Weigel; Anja Lemke; Burkhard Tönshoff; Lars Pape; Henry Fehrenbach; Michael Henn; Bernd Hoppe; Therese Jungraithmayr; Martin Konrad; Guido Laube; Martin Pohl; Tomáš Seeman; Hagen Staude; Markus J Kemper; Ulrike John Journal: Pediatr Nephrol Date: 2016-01-11 Impact factor: 3.714
Authors: Benjamin A Sherer; Krishnan Warrior; Karl Godlewski; Martin Hertl; Oyedolamu Olaitan; Ajay Nehra; Leslie Allan Deane Journal: Int Braz J Urol Date: 2017 Nov-Dec Impact factor: 1.541
Authors: Daniela Gerges-Knafl; Peter Pichler; Alexander Zimprich; Christoph Hotzy; Wolfgang Barousch; Rita M Lang; Elisabeth Lobmeyr; Sabina Baumgartner-Parzer; Ludwig Wagner; Wolfgang Winnicki Journal: BMC Nephrol Date: 2020-04-06 Impact factor: 2.388
Authors: Maria José Espinar; Isabel M Miranda; Sofia Costa-de-Oliveira; Rita Rocha; Acácio G Rodrigues; Cidália Pina-Vaz Journal: PLoS One Date: 2015-08-03 Impact factor: 3.240